This could include: Heart rate assessment at 4-8 weeks after initiation or dose escalation Periodic electrocardiography if arrhythmias are suspected Patient self-monitoring of pulse if symptomatic palpitations occur Evaluation of heart rate control in patients with atrial fibrillation When evaluating tachycardia in patients on GLP-1 therapy, clinicians should assess for other potential causes, including dehydration (especially from GI side effects), anemia, hyperthyroidism, stimulant use, infection, or other medications
Without the oversight that comes with FDA approval, products sold through unofficial websites or social media may not meet the same standards for purity, sterility or potency
The mechanism behind this
Sin lactosa, sacarosa, almidn ni sal aadidos
Visit our clinic at 4610 NE 77th Ave Suite 137 in Vancouver, Washington , and experience the benefits of IV hydration therapy in a comfortable, welcoming environment.